Allakos Inc. Faces Delisting Notice Following Merger with Concentra Biosciences

Allakos Inc. has received a delisting notice following its merger with Concentra Biosciences. The company requested Nasdaq to suspend trading of its shares before the market opened on May 15, 2025, and to file for removal from listing. Additionally, Allakos plans to terminate the registration of its shares with the SEC under the Securities Exchange Act of 1934.

Allakos Inc reports results for the quarter ended March 31 - Earnings Summary

Allakos IncQ) reported a quarterly adjusted loss of 29 cents per share for the quarter ended March 31, an improvement from a loss of 81 cents in the same quarter last year. The company's reported revenue was zero, matching analyst expectations. Allakos shares rose 44% this quarter but are down 72.9% year-to-date. Analysts maintain a "hold" rating, with a median 12-month price target of $0.40. No earnings estimate revisions occurred in the last 30 days.

Allakos | 10-Q: FY2025 Q1 EPS Meets Estimate at USD -0.29

Allakos IncQ) expected to post a loss of 29 cents a share - Earnings Preview

Allakos IncQ) is projected to report a loss of 29 cents per share for the quarter ending March 31, 2025, with no change in revenue expected. The average analyst rating is "hold," with a median 12-month price target of $0.40, above the last closing price of $0.33. Recent earnings estimates have decreased by 1.2% over the past three months. Previous quarterly performances show a mix of beats and misses against estimates.

12:42 ET SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COOP, HMST, ALLK, OPOF on Behalf of Shareholders

Halper Sadeh LLC is investigating Mr. Cooper Group Inc. (COOP), HomeStreet, Inc. (HMST), Allakos Inc. (ALLK), and Old Point Financial Corporation (OPOF) for potential violations of federal securities laws and breaches of fiduciary duties. The investigations relate to various proposed transactions, including COOP's sale to Rocket Companies, HMST's merger with Mechanics Bank, ALLK's sale to Concentra Biosciences, and OPOF's sale to TowneBank. Shareholders are encouraged to contact Halper Sadeh LLC for legal rights and options regarding these transactions.